ߜ The response of nonfluorescing infiltrating tumors that had been exposed to 5-aminolevulinic acid and irradiated using a laser at a wavelength of 405 nm was analyzed intraoperatively using spectroscopy. Histological analyses demonstrated that neoplastic cells were present in the tissue region that displayed a peak at 636 nm, whereas no neoplastic cells were present in the region that exhibited only the excitation light peak. The authors conclude that the intraoperative use of laser spectroscopy can allow the diagnosis of infiltrating tumor and the detection of boundaries of the infiltrate when standard fluorescence techniques fail.
UTOFLUORESCENCE allows the identification of tumors through an assessment of uptake of the heme precursor 5-ALA, which is rapidly metabolized by tumor cells into the fluorescent molecule protoporphyrin IX. 1 Exposure to an appropriate wavelength of light causes protoporphyrin IX to fluoresce at a 636-nm wavelength, 5 permitting the intraoperative diagnosis of neoplastic cells by differentiating them visibly from surrounding normal cells. 4, 8, 11 However, some infiltrating tumors and their marginal areas of infiltration may be subfluorescent. We therefore investigated the intraoperative use of laser spectroscopy to identify the presence of such tumors and to define the boundaries of infiltration for surgical treatment.
Clinical Material and Methods
Six patients, ranging in age from 30 to 57 years, participated in this study. None of these patients' tumors enhanced on MR imaging following the administration of Gd-diethylenetriamine pentaacetic acid. Two hours before induction of anesthesia, each patient was given a 1-g oral dose of 5-ALA. Tumor resection was performed between 4 and 6 hours after the administration of 5-ALA. The target region was exposed to a laser light that had a peak wavelength of 405 Ϯ 1 nm and a light output of 40 mW. The excitation light was delivered using a semiconductor laser device (VLD-V1 version 2: M & M Co., Ltd., Tokyo, Japan; Fig.  1 ). None of the tumors exhibited protoporphyrin IX fluorescence. The spectra of the response light from nonfluorescing tumors were analyzed. Because blood between a probe and tissue can obscure findings, histological analyses were performed on more than three samples obtained from nonbleeding areas of each tumor. Moreover, more than three samples were resected when different spectra of the response light were obtained. The fiber, which is fixed by a holder, leads to the purple semiconductor laser device used for the photodynamic diagnostic study and to the spectroscope.
Results
In three cases, protoporphyrin IX fluorescence was not observed in the target region, but a pale reflection of excitation light was visible. Spectroscopy revealed an amplitude peak at a wavelength of 636 nm in the area of the observed reflection (Fig. 2) . Histological analyses were performed on samples obtained in all three cases; in two cases three samples were studied, and in one case four samples were studied. The findings confirmed the presence of tumor cells in all areas showing an amplitude peak at 636 nm, leading to a diagnosis of typical diffuse astrocytoma (Fig. 3) . The specificity of these analyses was 100%. Histological analyses also were performed on samples from areas in which there had been no amplitude peak at 636 nm; in one case four samples were examined, in another five samples, and in the third case seven samples (Fig. 4) . In these areas few or no tumor cells were present, from which we inferred that these sites may be areas of infiltrate. Atypical tumor cells were observed in at least seven tissue samples, and the specificity of these analyses was 44%. The area that displayed an amplitude peak at 636 nm was nearly the same as the T 2 high-intensity area, and no amplitude peak at 636 nm was observed outside the T 2 margin.
Discussion
The heme precursor 5-ALA is rapidly metabolized by tumor cells into the fluorescent molecule protoporphyrin IX. 1, 2 Exposure to an appropriate wavelength of light causes protoporphyrin IX to fluoresce, allowing the investigator to differentiate neoplastic cells from the surrounding normal cells. 6 Intraoperatively, exposure to ultraviolet light causes protoporphyrin IX to fluoresce red at the 636-nm wavelength, 4, 10, 11 permitting the diagnosis of tumors and the definition of tumor boundaries for surgical treatment. Nevertheless, some forms of tumor do not fluoresce, 3, 4 making a diagnosis difficult. Other tumors, particularly infiltrating tumors, may fluoresce at their centers, but their fluorescence diminishes in intensity so dramatically in regions of infiltrate that the boundaries of the tumor are impossible to observe. 8 To some extent, the intensity of the fluorescence is proportional to the quantity of neoplastic cells. 8 In cells with normal cytokinesis, uptake of 5-ALA is easy. 7, 9 However, in cases of diffuse astrocytoma, the density and division poten-
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Laser spectroscopy for intraoperative detection of brain tumors 619 FIG. 2. Spectrum tracing demonstrating intensity when an excitation light is applied to a tumor. A high peak is found at 405 nm (thin arrow), which is the excitation light wavelength, and a low peak is found at 636 nm (thick arrow), which is the fluorescence of protoporphyrin IX. tial of cells is not high, and thus, the uptake of 5-ALA is limited, resulting in very small amounts of protoporphyrin IX. Although this molecule is present, the amount accumulated in tumor cells is too small to produce visible fluorescence. Using our method, we were able to detect a minute amount of protoporphyrin IX at the 636-nm wavelength and were able to determine the presence of a tumor objectively. Our findings in the present study indicate that spectrum analysis surpasses fluorescence recognition in the detection of very small amounts of protoporphyrin IX. We were able to identify three diffuse astrocytomas and to delineate the boundary regions of these infiltrating tumors intraoperatively. These results suggest that spectrum analysis may provide the surgeon with an effective diagnostic tool to assess intraoperatively the definition of a nonfluorescent tumor and to demarcate the boundaries of an infiltrating tumor in cases in which the fluorescence is too faint to be observed. Because the surgical team can chemically navigate the tumor in real time, this procedure is useful for the surgical removal of a tumor including portions invading other areas. When using a conventional imaging technique, such as ultrasonography, an artifact in the form of a tumor resection stump is observed. When using the described methods, on the other hand, an artifact is not observed and we can reduce the remainder of the tumor stump cells.
